Skip to main content Accessibility help
×
Home

Transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2

  • Li-Jian Zhao (a1), Bo Han (a1), Jian-Jun Zhang (a1), Ying-Chun Yi (a1), Dian-Dong Jiang (a1) and Jian-Li Lyu (a1)...

Abstract

Objective

The objective of this study was to explore the clinical effect of the transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2.

Methods

Between February 2012 and December 2016, 51 patients were subjected to Amplatzer duct occluder 2 for transcatheter closure of perimembranous ventricular septal defect. A total of 51 patients with perimembranous ventricular septal defect who underwent transcatheter closure by the conventional membranous ventricular septal occluder comprised the control group. The success rate and complications were compared, and indications of Amplatzer duct occluder 2 for perimembranous ventricular septal defect were explored.

Results

The success rate of the interventional procedure was 98.0% (50/51) in the group of Amplatzer duct occluder 2 versus 100% in the group of conventional membranous ventricular septal occluder. The mean age of the patients of Amplatzer duct occluder group was 5.0±3.7 years (range: 1.5–25.0), and the mean weight was 19.3±8.1 kg (range: 11.0–52.0). The mean outlet diameter of the defects was 2.8±0.6 mm (range: 1.8–5.1) as measured by transthoracic echocardiography. The device was implanted by a retrograde approach in 40 patients and antegrade approach in 10 patients. No statistical significance was observed in the incidence of complication and hospitalisation duration between the two groups; however, the Amplatzer duct occluder 2 group was cost-effective (p<0.05) and required less fluoroscopy time (p<0.05). Neither deaths nor new onset of aortic and tricuspid insufficiency occurred during the median 26.2 months (range: 3–65) of follow-up.

Conclusions

Amplatzer duct occluder 2 has advantages of simple manipulation and less medical costs compared with conventional device in transcatheter closure of small type perimembranous ventricular septal defect.

Copyright

Corresponding author

Correspondence to: Dr B. Han, Department of Pediatric Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China. Tel: 13605313927; E-mail: hanbo35@163.com

References

Hide All
1. Hoffman, JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995; 16: 103113.
2. Hoffman, JI, Kaplan, S, Liberthson, RR. Prevalence of congenital heart disease. Am Heart J 2004; 147: 425439.
3. Saurav, A, Kaushik, M, Mahesh Alla, V, et al. Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2015; 86: 10481056.
4. Bai, Y, Liu, J, Qin, YW, Wu, H, Zhao, XX. Percutaneous closure of perimembranous ventricular septal defect with modified double-disk occluder: what Is the outcome at 10-year follow-up? Congenit Heart Dis 2015; 11: 45–51.
5. Yang, J, Yang, L, Yu, S, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol 2014; 63: 11591168.
6. El-Sisi, A, Sobhy, R, Jaccoub, V, Hamza, H. Perimembranous ventricular septal defect device closure: choosing between amplatzer duct occluder I and II. Pediatric Cardiol 2017; 38: 596602.
7. Zhao, PJ, Yu, ZQ, Gao, W, et al. Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II. Zhonghua Xin Xue Guan Bing Za Zhi 2012; 40: 817820.
8. Koneti, NR, Penumatsa, RR, Kanchi, V, et al. Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II. Catheter Cardiovasc Interv 2011; 77: 252259.
9. Polat, TB, Turkmen, E. Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience. Postepy Kardiol Interwencyjnej 2016; 12: 340347.
10. Zuo, J, Xie, J, Yi, W, et al. Results of transcatheter closure of perimembranous ventricular septal defect. Am J Cardiol 2010; 106: 10341037.
11. Zhou, T, Shen, XQ, Zhou, SH, et al. Atrioventricular block: a serious complication in and after transcatheter closure of perimembranous ventricular septal defects. Clin Cardiol 2008; 31: 368371.
12. Zhou, D, Pan, W, Guan, L, Ge, J. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder. Catheter Cardiovasc Interv 2012; 79: 666674.
13. Yang, L, Tai, BC, Khin, LW, Quek, SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol 2014; 27: 260272.
14. Kanaan, M, Ewert, P, Berger, F, Assa, S, Schubert, S. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer duct occluder II. Pediatr Cardiol 2015; 36: 379–385.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed